Clinical Trial Update: Effect of Food on BIA 6-512 (Trans-resveratrol) [Phase 1]

View source ↗

Summary

A Phase 1 study update reports on the effect of food on exposure to BIA 6-512 (trans-resveratrol) in Parkinson's disease, and the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Trans-resveratrol (BIA 6-512) (trans-resveratrol)

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Parkinson Disease | Phase 1 | Status: COMPLETED